Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,959 public trials 3,762 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

NCT05640999

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Alaska Womens Cancer Care Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Huntington Memorial Hospital Pasadena, California, United States
View all 121 locations
View Trial Details
Recruiting

Sentinel Node Biopsy in Endometrial Cancer

NCT04073706

Conditions
Endometrial Cancer Stage I, Endometrial Neoplasms, Female Urogenital Diseases, +12 more
Locations
  • Houston Methodist Hospital Houston, Texas, United States
  • Hospital Britanico Buenos Aires, Ciudad Autónoma de Buenos Aires (caba), Argentina
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
  • Liverpool Hospital Liverpool, New South Wales, Australia
View all 23 locations
View Trial Details
Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy
  • IRCCS Ospedale San Raffaele Milan, Segrate, Italy
View Trial Details
Recruiting

A Study of Isoquercetin in People With Ovarian Cancer

NCT07303894

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations
  • Beth Israel Deaconess Medical Center (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT05739981

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Johns Hopkins Medicine SKCCC Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • OU Health, Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions